These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 17016757)
21. Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression. Russell JM; Koran LM; Rush J; Hirschfeld RM; Harrison W; Friedman ES; Davis S; Keller M Depress Anxiety; 2001; 13(1):18-27. PubMed ID: 11233456 [TBL] [Abstract][Full Text] [Related]
24. Antidepressant efficacy and safety of low-dose sertraline and standard-dose imipramine for the treatment of depression in older adults: results from a double-blind, randomized, controlled clinical trial. Forlenza OV; Almeida OP; Stoppe A; Hirata ES; Ferreira RCR Int Psychogeriatr; 2001 Mar; 13(1):75-84. PubMed ID: 11352337 [TBL] [Abstract][Full Text] [Related]
25. [Hyperpigmentation of the face]. Dissemond J; Franckson T; Fitz G; Hillen U; Goos M Hautarzt; 2003 Oct; 54(10):994-8. PubMed ID: 14513255 [No Abstract] [Full Text] [Related]
27. Switching from imipramine to sertraline in panic disorder. Mavissakalian MR J Psychiatr Pract; 2004 Mar; 10(2):88-94. PubMed ID: 15330404 [TBL] [Abstract][Full Text] [Related]
28. Gender differences in treatment response to sertraline versus imipramine in chronic depression. Kornstein SG; Schatzberg AF; Thase ME; Yonkers KA; McCullough JP; Keitner GI; Gelenberg AJ; Davis SM; Harrison WM; Keller MB Am J Psychiatry; 2000 Sep; 157(9):1445-52. PubMed ID: 10964861 [TBL] [Abstract][Full Text] [Related]
29. Double-blind study of the efficacy and safety of milnacipran and imipramine in elderly patients with major depressive episode. Tignol J; Pujol-Domenech J; Chartres JP; Léger JM; Plétan Y; Tonelli I; Tournoux A; Pezous N Acta Psychiatr Scand; 1998 Feb; 97(2):157-65. PubMed ID: 9517912 [TBL] [Abstract][Full Text] [Related]
30. Photodistribution of blue-gray hyperpigmentation after amiodarone treatment: molecular characterization of amiodarone in the skin. Ammoury A; Michaud S; Paul C; Prost-Squarcioni C; Alvarez F; Lamant L; Launay F; Bazex J; Chouini-Lalanne N; Marguery MC Arch Dermatol; 2008 Jan; 144(1):92-6. PubMed ID: 18209173 [TBL] [Abstract][Full Text] [Related]
31. Exogenous ochronosis--a diagnostic challenge. Tan SK J Cosmet Dermatol; 2010 Dec; 9(4):313-7. PubMed ID: 21122051 [TBL] [Abstract][Full Text] [Related]
32. Extensive cutaneous hyperpigmentation caused by minocycline. Pepine M; Flowers FP; Ramos-Caro FA J Am Acad Dermatol; 1993 Feb; 28(2 Pt 2):292-5. PubMed ID: 8436641 [TBL] [Abstract][Full Text] [Related]
33. Delayed darkening of imipramine-induced hyperpigmentation after treatment with a Q-switched Nd:YAG laser followed by a Q-switched ruby laser. Izikson L; Anderson RR Dermatol Surg; 2009 Mar; 35(3):527-9. PubMed ID: 19250303 [No Abstract] [Full Text] [Related]
34. Serotonin syndrome: case report and review of the literature. Weiner AL; Tilden FF; McKay CA Conn Med; 1997 Nov; 61(11):717-21. PubMed ID: 9419960 [TBL] [Abstract][Full Text] [Related]